IHSG ends higher as vaccine efficacy boosts investor sentiment

IHSG ends higher as vaccine efficacy boosts investor sentiment

Illustration - Positive sentiment over the COVID-19 vaccine caused the IHSG to strengthen 106.73 points, or 1.99 percent, to reach 5,462.74 on Tuesday (Nov 10). REUTERS/Dado Ruvic/Illustration/File Photo (REUTERS/DADO RUVIC)

The IHSG strengthened today owing to external factors, including Pfizer's (COVID-19) vaccine.
Jakarta (ANTARA) - The Jakarta Composite Index (IHSG) ended higher on Tuesday as efficacy of the COVID-19 vaccine raised investor sentiment.

Index of the Indonesian Stock Exchange (BEI) rose 106.73 points, or 1.99 percent, to reach 5,462.74, while index of the 45 most liquid stocks (LQ45) gained 23.45 points, or 2.79 percent, to touch 834.9.

"The IHSG strengthened today owing to external factors, including Pfizer's (COVID-19) vaccine," Indo Premier Sekuritas analyst Mino noted.

Pfizer Inc reported that its experimental COVID-19 vaccine is over 90-percent effective.

After opening higher on Tuesday, the IHSG remained in the positive territory until the close of trade.

Stocks in all nine sectors rose, led by the financial sector, jumping 3.94 percent, followed by the basic industry and miscellaneous industry that climbed 2.42 percent and 2.26 percent respectively.

Tuesday’s trade posted net foreign purchases of Rp1.79 trillion.

A total of 1,048,619 transactions were recorded on Tuesday, with 16.14 billion shares, worth Rp15.42 trillion, changing hands. Meanwhile, 275 shares rose, 178 shares fell, and 158 shares remained unchanged.

In the Asian regional markets, the Nikkei index gained 65.75 points, or 0.26 percent, to 24,905.59; the Hang Seng Index increased 285.31 points, or 1.1 percent, to 26,301.48; while the Straits Times Index rose 88.55 points, or 3.39 percent, to reach 2,697.71.
Related news: IHSG ends higher on hopes of national economic recovery

Related news: IHSG ends lower as caution sets in amid tight US vote